Back to Search
Start Over
Hospitalization Rates in COLUMBUS Part 1: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus Vemurafenib (VEM) or ENCO in BRAF-Mutant Melanoma
- Source :
- Web of Science, Publons
- Subjects :
- medicine.medical_specialty
business.industry
Melanoma
Mutant
Binimetinib
Hematology
medicine.disease
Dermatology
030207 dermatology & venereal diseases
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Oncology
chemistry
030220 oncology & carcinogenesis
Encorafenib
medicine
Cancer research
Vemurafenib
business
medicine.drug
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Web of Science, Publons
- Accession number :
- edsair.doi.dedup.....a40be0ee97ddbc7a129ca2535223097c